Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 117

1.

Heart Failure With Preserved Ejection Fraction Expert Panel Report: Current Controversies and Implications for Clinical Trials.

Parikh KS, Sharma K, Fiuzat M, Surks HK, George JT, Honarpour N, Depre C, Desvigne-Nickens P, Nkulikiyinka R, Lewis GD, Gomberg-Maitland M, O'Connor CM, Stockbridge N, Califf RM, Konstam MA, Januzzi JL Jr, Solomon SD, Borlaug BA, Shah SJ, Redfield MM, Felker GM.

JACC Heart Fail. 2018 Aug;6(8):619-632. doi: 10.1016/j.jchf.2018.06.008. Review.

PMID:
30071950
2.

Psychometric Validation of the Pulmonary Arterial Hypertension-Symptoms and Impact (PAH-SYMPACT) Questionnaire: Results of the SYMPHONY Trial.

Chin KM, Gomberg-Maitland M, Channick RN, Cuttica MJ, Fischer A, Frantz RP, Hunsche E, Kleinman L, McConnell JW, McLaughlin VV, Miller CE, Zamanian RT, Zastrow MS, Badesch DB.

Chest. 2018 Oct;154(4):848-861. doi: 10.1016/j.chest.2018.04.027. Epub 2018 Apr 26.

3.

A 70-Year-Old Woman Presenting With Diarrhea and In-hospital Cardiac Arrest.

Jose A, Franco-Palacios D, King CS, Gomberg-Maitland M.

Chest. 2018 Jan;153(1):e5-e8. doi: 10.1016/j.chest.2017.07.042. No abstract available.

PMID:
29307435
4.

Assessing risk in pulmonary arterial hypertension: what we know, what we don't.

Benza RL, Farber HW, Selej M, Gomberg-Maitland M.

Eur Respir J. 2017 Aug 3;50(2). pii: 1701353. doi: 10.1183/13993003.01353-2017. Print 2017 Aug. No abstract available.

PMID:
28775053
5.

Uncovering Small Secrets in Big Data Sets: How Math Can Identify Biology in Rare Conditions (Pediatric Pulmonary Hypertension).

Gomberg-Maitland M, Souza R.

Circ Res. 2017 Aug 4;121(4):317-319. doi: 10.1161/CIRCRESAHA.117.311511. No abstract available.

PMID:
28775006
6.

Totally Implantable IV Treprostinil Therapy in Pulmonary Hypertension Assessment of the Implantation Procedure.

Waxman AB, McElderry HT, Gomberg-Maitland M, Burke MC, Ross EL, Bersohn MM, Pangarkar SS, Tarver JH, Zwicke DL, Feldman JP, Chakinala MM, Frantz RP, Thompson GB, Torres F, Rauck RL, Clagg K, Durst L, Li P, Morris M, Southall KL, Peterson L, Bourge RC.

Chest. 2017 Dec;152(6):1128-1134. doi: 10.1016/j.chest.2017.04.188. Epub 2017 Jun 3.

PMID:
28583617
7.

Utility of B-type natriuretic peptides in the assessment of patients with systemic sclerosis-associated pulmonary hypertension in the PHAROS registry.

Chung L, Fairchild RM, Furst DE, Li S, Alkassab F, Bolster MB, Csuka ME, Derk CT, Domsic RT, Fischer A, Frech TM, Gomberg-Maitland M, Gordon JK, Hinchcliff M, Hsu V, Hummers LK, Khanna D, Medsger TAJ, Molitor JA, Preston IR, Schiopu E, Shapiro L, Hant F, Silver R, Simms R, Varga J, Steen VD, Zamanian RT.

Clin Exp Rheumatol. 2017 Sep-Oct;35 Suppl 106(4):106-113. Epub 2016 Nov 10.

PMID:
27908301
8.

Group 5 Pulmonary Hypertension: The Orphan's Orphan Disease.

Kalantari S, Gomberg-Maitland M.

Cardiol Clin. 2016 Aug;34(3):443-9. doi: 10.1016/j.ccl.2016.04.004. Review.

9.

Treprostinil Administered to Treat Pulmonary Arterial Hypertension Using a Fully Implantable Programmable Intravascular Delivery System: Results of the DelIVery for PAH Trial.

Bourge RC, Waxman AB, Gomberg-Maitland M, Shapiro SM, Tarver JH 3rd, Zwicke DL, Feldman JP, Chakinala MM, Frantz RP, Torres F, Cerkvenik J, Morris M, Thalin M, Peterson L, Rubin LJ.

Chest. 2016 Jul;150(1):27-34. doi: 10.1016/j.chest.2015.11.005. Epub 2016 Jan 13.

10.

Continuing Medical Education Activity in Echocardiography: May 2016.

Mediratta A, Addetia K, Medvedofsky D, Gomberg-Maitland M, Mor-Avi V, Lang RM.

Echocardiography. 2016 May;33(5):695. doi: 10.1111/echo.13248. No abstract available.

11.

Applying Rasch analysis to evaluate measurement equivalence of different administration formats of the Activity Limitation scale of the Cambridge Pulmonary Hypertension Outcome Review (CAMPHOR).

Twiss J, McKenna SP, Graham J, Swetz K, Sloan J, Gomberg-Maitland M.

Health Qual Life Outcomes. 2016 Apr 9;14:57. doi: 10.1186/s12955-016-0462-2.

12.

Telangiectasia and Pulmonary Arterial Hypertension Following Treatment With Trastuzumab Emtansine: A Case Report.

Kwon Y, Gomberg-Maitland M, Pritzker M, Thenappan T.

Chest. 2016 Apr;149(4):e103-5. doi: 10.1016/j.chest.2015.09.008.

PMID:
27055712
13.

Using Registries to Understand Clinical Practice: A Lesson for Rare Disease.

Gomberg-Maitland M, Rosenzweig EB.

J Am Coll Cardiol. 2016 Mar 22;67(11):1324-6. doi: 10.1016/j.jacc.2015.12.057. No abstract available.

14.

Inflammation in Heart Failure With Preserved Ejection Fraction: Time to Put Out the Fire.

Gomberg-Maitland M, Shah SJ, Guazzi M.

JACC Heart Fail. 2016 Apr;4(4):325-8. doi: 10.1016/j.jchf.2015.11.013. Epub 2016 Feb 10. No abstract available.

15.

Tricuspid regurgitation progression and regression in pulmonary arterial hypertension: implications for right ventricular and tricuspid valve apparatus geometry and patients outcome.

Medvedofsky D, Aronson D, Gomberg-Maitland M, Thomeas V, Rich S, Spencer K, Mor-Avi V, Addetia K, Lang RM, Shiran A.

Eur Heart J Cardiovasc Imaging. 2017 Jan;18(1):86-94. doi: 10.1093/ehjci/jew010. Epub 2016 Feb 11.

PMID:
26873457
16.

Physiologic Markers of Exercise as a Potential Screening Tool for the Detection of Pulmonary Hypertension: "α" Few Steps Forward.

Agarwal R, Gomberg-Maitland M.

Chest. 2016 Feb;149(2):295-297. doi: 10.1016/j.chest.2015.08.024. No abstract available.

PMID:
26867825
17.

Phase I safety study of ranolazine in pulmonary arterial hypertension.

Gomberg-Maitland M, Schilz R, Mediratta A, Addetia K, Coslet S, Thomeas V, Gillies H, Oudiz RJ.

Pulm Circ. 2015 Dec;5(4):691-700. doi: 10.1086/683813.

18.

Echocardiographic Diagnosis of Acute Pulmonary Embolism in Patients with McConnell's Sign.

Mediratta A, Addetia K, Medvedofsky D, Gomberg-Maitland M, Mor-Avi V, Lang RM.

Echocardiography. 2016 May;33(5):696-702. doi: 10.1111/echo.13142. Epub 2015 Dec 15.

19.

Cardiac MRI right ventricle / left ventricle (RV/LV) volume ratio improves detection of RV enlargement.

Altmayer SP, Patel AR, Addetia K, Gomberg-Maitland M, Forfia PR, Han Y.

J Magn Reson Imaging. 2016 Jun;43(6):1379-85. doi: 10.1002/jmri.25110. Epub 2015 Dec 9.

PMID:
26646199
20.

Prostacyclin and oral vasodilator therapy in sarcoidosis-associated pulmonary hypertension: a retrospective case series.

Bonham CA, Oldham JM, Gomberg-Maitland M, Vij R.

Chest. 2015 Oct;148(4):1055-1062. doi: 10.1378/chest.14-2546.

21.

Endothelin-1 Pathway Polymorphisms and Outcomes in Pulmonary Arterial Hypertension.

Benza RL, Gomberg-Maitland M, Demarco T, Frost AE, Torbicki A, Langleben D, Pulido T, Correa-Jaque P, Passineau MJ, Wiener HW, Tamari M, Hirota T, Kubo M, Tiwari HK.

Am J Respir Crit Care Med. 2015 Dec 1;192(11):1345-54. doi: 10.1164/rccm.201501-0196OC.

22.

Reply: Perspectives on Oral Pulmonary Hypertension Therapies Recently Approved by the U.S. Food and Drug Administration.

Hill NS, Badesch D, Benza RL, D'Eletto TA, Farber HW, Gomberg-Maitland M, Hassoun PM, Preston I.

Ann Am Thorac Soc. 2015 Jun;12(6):960. doi: 10.1513/AnnalsATS.201505-263LE. No abstract available.

PMID:
26075562
23.

Management of pulmonary hypertension and right heart failure in the intensive care unit.

Grinstein J, Gomberg-Maitland M.

Curr Hypertens Rep. 2015 May;17(5):32. doi: 10.1007/s11906-015-0547-z. Review.

PMID:
25833459
24.

Quality of life, safety and efficacy profile of thermostable flolan in pulmonary arterial hypertension.

Provencher S, Paruchuru P, Spezzi A, Waterhouse B, Gomberg-Maitland M; pH12 Flolan reformulation study group.

PLoS One. 2015 Mar 20;10(3):e0120657. doi: 10.1371/journal.pone.0120657. eCollection 2015.

25.

Intravenous fasudil improves in-hospital mortality of patients with right heart failure in severe pulmonary hypertension.

Jiang R, Ai ZS, Jiang X, Yuan P, Liu D, Zhao QH, He J, Wang L, Gomberg-Maitland M, Jing ZC.

Hypertens Res. 2015 Aug;38(8):539-44. doi: 10.1038/hr.2015.33. Epub 2015 Mar 19.

PMID:
25787034
26.

[New trial designs and potential therapies for pulmonary artery hypertension].

Gomberg-Maitland M, Bull TM, Saggar R, Barst RJ, Elgazayerly A, Fleming TR, Grimminger F, Rainisio M, Stewart DJ, Stockbridge N, Ventura C, Ghofrani AH, Rubin LJ.

Turk Kardiyol Dern Ars. 2014 Oct;42 Suppl 1:106-18. Turkish.

27.

Perspectives on oral pulmonary hypertension therapies recently approved by the U.S. Food and Drug Administration.

Hill NS, Badesch D, Benza RL, D'Eletto TA, Farber HW, Gomberg-Maitland M, Hassoun PM, Preston I.

Ann Am Thorac Soc. 2015 Feb;12(2):269-73. doi: 10.1513/AnnalsATS.201501-020AS.

PMID:
25590376
28.

Pulmonary hypertension in heart failure with preserved ejection fraction.

Guazzi M, Gomberg-Maitland M, Arena R.

J Heart Lung Transplant. 2015 Mar;34(3):273-81. doi: 10.1016/j.healun.2014.11.003. Epub 2014 Nov 8. Review.

PMID:
25577563
29.

Impact of pharmacologic interventions--treating endothelial dysfunction and group 2 pulmonary hypertension.

Guazzi M, Gomberg-Maitland M, Naeije R.

Prog Cardiovasc Dis. 2015 Mar-Apr;57(5):473-9. doi: 10.1016/j.pcad.2014.11.002. Epub 2014 Nov 11.

PMID:
25446553
30.

Pulmonary hypertension and interstitial lung disease within PHAROS: impact of extent of fibrosis and pulmonary physiology on cardiac haemodynamic parameters.

Fischer A, Swigris JJ, Bolster MB, Chung L, Csuka ME, Domsic R, Frech T, Hinchcliff M, Hsu V, Hummers LK, Gomberg-Maitland M, Mathai SC, Simms R, Steen VD.

Clin Exp Rheumatol. 2014 Nov-Dec;32(6 Suppl 86):S-109-14. Epub 2014 Nov 4.

PMID:
25372796
31.

New pharmacotherapies for pulmonary hypertension: where do they fit in?

Wolfson AM, Steiger N, Gomberg-Maitland M.

Curr Hypertens Rep. 2014 Dec;16(12):496. doi: 10.1007/s11906-014-0496-y. Review.

PMID:
25304107
32.

β-blocker therapy is not associated with adverse outcomes in patients with pulmonary arterial hypertension: a propensity score analysis.

Thenappan T, Roy SS, Duval S, Glassner-Kolmin C, Gomberg-Maitland M.

Circ Heart Fail. 2014 Nov;7(6):903-10. doi: 10.1161/CIRCHEARTFAILURE.114.001429. Epub 2014 Oct 2.

PMID:
25277998
33.

Epidemiology of pulmonary hypertension and right ventricular failure in left heart failure.

Thenappan T, Gomberg-Maitland M.

Curr Heart Fail Rep. 2014 Dec;11(4):428-35. doi: 10.1007/s11897-014-0216-6. Review.

PMID:
25135469
34.

Right ventricular strain in pulmonary arterial hypertension: a 2D echocardiography and cardiac magnetic resonance study.

Freed BH, Tsang W, Bhave NM, Patel AR, Weinert L, Yamat M, Vicedo BM, Dill K, Mor-Avi V, Gomberg-Maitland M, Lang RM.

Echocardiography. 2015 Feb;32(2):257-63. doi: 10.1111/echo.12662. Epub 2014 Jun 28.

PMID:
24975738
35.

Measuring health in pulmonary hypertension: emphasising the right end-point?

Gomberg-Maitland M, Chen H.

Eur Respir J. 2014 Apr;43(4):960-2. doi: 10.1183/09031936.00001014. No abstract available.

36.

CT-based pulmonary artery measurements for the assessment of pulmonary hypertension.

Corson N, Armato SG 3rd, Labby ZE, Straus C, Starkey A, Gomberg-Maitland M.

Acad Radiol. 2014 Apr;21(4):523-30. doi: 10.1016/j.acra.2013.12.015.

37.

New trial designs and potential therapies for pulmonary artery hypertension.

Gomberg-Maitland M, Bull TM, Saggar R, Barst RJ, Elgazayerly A, Fleming TR, Grimminger F, Rainisio M, Stewart DJ, Stockbridge N, Ventura C, Ghofrani AH, Rubin LJ.

J Am Coll Cardiol. 2013 Dec 24;62(25 Suppl):D82-91. doi: 10.1016/j.jacc.2013.10.026. Review.

38.

Sample size and cost analysis for pulmonary arterial hypertension drug trials using various imaging modalities to assess right ventricular size and function end points.

Addetia K, Bhave NM, Tabit CE, Gomberg-Maitland M, Freed BH, Dill KE, Lang RM, Mor-Avi V, Patel AR.

Circ Cardiovasc Imaging. 2014 Jan;7(1):115-24. doi: 10.1161/CIRCIMAGING.113.000932. Epub 2013 Nov 5.

PMID:
24192452
39.

Pulmonary arterial hypertension with right ventricular failure: the left forgotten ventricle.

Freed BH, Gomberg-Maitland M.

Chest. 2013 Nov;144(5):1435-1436. doi: 10.1378/chest.13-1193. No abstract available.

PMID:
24189851
40.

Survival in pulmonary arterial hypertension patients awaiting lung transplantation.

Gomberg-Maitland M, Glassner-Kolmin C, Watson S, Frantz R, Park M, Frost A, Benza RL, Torres F.

J Heart Lung Transplant. 2013 Dec;32(12):1179-86. doi: 10.1016/j.healun.2013.08.016. Epub 2013 Sep 25.

PMID:
24074527
41.

Survival and predictors of mortality in systemic sclerosis-associated pulmonary arterial hypertension: outcomes from the pulmonary hypertension assessment and recognition of outcomes in scleroderma registry.

Chung L, Domsic RT, Lingala B, Alkassab F, Bolster M, Csuka ME, Derk C, Fischer A, Frech T, Furst DE, Gomberg-Maitland M, Hinchcliff M, Hsu V, Hummers LK, Khanna D, Medsger TA Jr, Molitor JA, Preston IR, Schiopu E, Shapiro L, Silver R, Simms R, Varga J, Gordon JK, Steen VD.

Arthritis Care Res (Hoboken). 2014 Mar;66(3):489-95. doi: 10.1002/acr.22121.

42.

One-year experience with intravenous treprostinil for pulmonary arterial hypertension.

Benza RL, Tapson VF, Gomberg-Maitland M, Poms A, Barst RJ, McLaughlin VV.

J Heart Lung Transplant. 2013 Sep;32(9):889-96. doi: 10.1016/j.healun.2013.06.008.

PMID:
23953817
43.

Long-term effects of continuous prostacyclin therapy in adults with pulmonary hypertension associated with congenital heart disease.

Thomas IC, Glassner-Kolmin C, Gomberg-Maitland M.

Int J Cardiol. 2013 Oct 9;168(4):4117-21. doi: 10.1016/j.ijcard.2013.07.072. Epub 2013 Jul 25.

PMID:
23890862
44.

Three-dimensional modeling of the right ventricle from two-dimensional transthoracic echocardiographic images: utility of knowledge-based reconstruction in pulmonary arterial hypertension.

Bhave NM, Patel AR, Weinert L, Yamat M, Freed BH, Mor-Avi V, Gomberg-Maitland M, Lang RM.

J Am Soc Echocardiogr. 2013 Aug;26(8):860-7. doi: 10.1016/j.echo.2013.05.007. Epub 2013 Jun 13.

PMID:
23768691
45.

Author's reply.

Cork DP, Mehrotra AK, Gomberg-Maitland M.

Pulm Circ. 2013 Jan;3(1):123-4. No abstract available.

46.

Referral of patients with pulmonary hypertension diagnoses to tertiary pulmonary hypertension centers: the multicenter RePHerral study.

Deaño RC, Glassner-Kolmin C, Rubenfire M, Frost A, Visovatti S, McLaughlin VV, Gomberg-Maitland M.

JAMA Intern Med. 2013 May 27;173(10):887-93. doi: 10.1001/jamainternmed.2013.319.

PMID:
23568223
47.

Outcomes of noncardiac, nonobstetric surgery in patients with PAH: an international prospective survey.

Meyer S, McLaughlin VV, Seyfarth HJ, Bull TM, Vizza CD, Gomberg-Maitland M, Preston IR, Barberà JA, Hassoun PM, Halank M, Jaïs X, Nickel N, Hoeper MM, Humbert M.

Eur Respir J. 2013 Jun;41(6):1302-7. doi: 10.1183/09031936.00089212. Epub 2012 Nov 8.

48.

Takotsubo cardiomyopathy after treatment of pulmonary arterial hypertension.

Cork DP, Mehrotra AK, Gomberg-Maitland M.

Pulm Circ. 2012 Jul;2(3):390-4. doi: 10.4103/2045-8932.101659.

49.

Development of prognostic tools in pulmonary arterial hypertension: lessons from modern day registries.

Benza RL, Gomberg-Maitland M, Frost AE, Frantz RP, Humbert M, McGoon MD.

Thromb Haemost. 2012 Dec;108(6):1049-60. doi: 10.1160/TH11-11-0821. Epub 2012 Sep 5. Review.

PMID:
22955290
50.

Survivor bias and risk assessment.

Miller DP, Gomberg-Maitland M, Humbert M.

Eur Respir J. 2012 Sep;40(3):530-2. doi: 10.1183/09031936.00094112. No abstract available.

Supplemental Content

Loading ...
Support Center